Monitoring Lipids in Patients Treated With Ziprasidone or Aripiprazole

Article Type
Changed
Display Headline
Monitoring Lipids in Patients Treated With Ziprasidone or Aripiprazole
Consensus Guidelines

Article PDF
Author and Disclosure Information

Shaiza Khan, PharmD; and Jennifer Zacher, PharmD, BCPP

Dr. Khan and Dr. Zacher are clinical pharmacy specialists at the North Chicago VA Medical Center in Illinois.

Issue
Federal Practitioner - 27(11)
Publications
Page Number
35
Legacy Keywords
lipids, ziprasidone, aripiprazole, antipsychotic medication, first-generation antipsychotics, FGA, second-generation antipsychotics, SGA, consensus guidelines, obestiy, diabetes, dylipidemia, cardiovascular disease, American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesitylipids, ziprasidone, aripiprazole, antipsychotic medication, first-generation antipsychotics, FGA, second-generation antipsychotics, SGA, consensus guidelines, obestiy, diabetes, dylipidemia, cardiovascular disease, American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
Sections
Author and Disclosure Information

Shaiza Khan, PharmD; and Jennifer Zacher, PharmD, BCPP

Dr. Khan and Dr. Zacher are clinical pharmacy specialists at the North Chicago VA Medical Center in Illinois.

Author and Disclosure Information

Shaiza Khan, PharmD; and Jennifer Zacher, PharmD, BCPP

Dr. Khan and Dr. Zacher are clinical pharmacy specialists at the North Chicago VA Medical Center in Illinois.

Article PDF
Article PDF
Consensus Guidelines
Consensus Guidelines

Issue
Federal Practitioner - 27(11)
Issue
Federal Practitioner - 27(11)
Page Number
35
Page Number
35
Publications
Publications
Article Type
Display Headline
Monitoring Lipids in Patients Treated With Ziprasidone or Aripiprazole
Display Headline
Monitoring Lipids in Patients Treated With Ziprasidone or Aripiprazole
Legacy Keywords
lipids, ziprasidone, aripiprazole, antipsychotic medication, first-generation antipsychotics, FGA, second-generation antipsychotics, SGA, consensus guidelines, obestiy, diabetes, dylipidemia, cardiovascular disease, American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesitylipids, ziprasidone, aripiprazole, antipsychotic medication, first-generation antipsychotics, FGA, second-generation antipsychotics, SGA, consensus guidelines, obestiy, diabetes, dylipidemia, cardiovascular disease, American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
Legacy Keywords
lipids, ziprasidone, aripiprazole, antipsychotic medication, first-generation antipsychotics, FGA, second-generation antipsychotics, SGA, consensus guidelines, obestiy, diabetes, dylipidemia, cardiovascular disease, American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesitylipids, ziprasidone, aripiprazole, antipsychotic medication, first-generation antipsychotics, FGA, second-generation antipsychotics, SGA, consensus guidelines, obestiy, diabetes, dylipidemia, cardiovascular disease, American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media